Maxim E. Rozanov
5 Papers
127 Citations
Maxim E. Rozanov is an academic researcher. The author has contributed to research in topics: Breast cancer & Cancer. The author has an hindex of 5, co-authored 5 publications.
Chat about Author
Papers
High frequency of BRCA1 5382insC mutation in Russian breast cancer patients
Anna P. Sokolenko,Natalia V. Mitiushkina,Konstantin G. Buslov,Elena M. Bit-Sava,Aglaya G. Iyevleva,Elena V. Chekmariova,Ekatherina Sh. Kuligina,Yulia M. Ulibina,Maxim E. Rozanov,Evgeny N. Suspitsin,Matsko De,Oleg L. Chagunava,Dmitry Yu. Trofimov,Peter Devilee,Cees J. Cornelisse,Alexandr V. Togo,Vladimir Semiglazov,Evgeny N. Imyanitov +17 more
TL;DR: Evaluated data confirm a noticeable contribution of BRCA1 5382insC mutation in BC development in Russia, that may justify an extended BRC a 5382inC testing within this population, and confirm none of 478 middle-aged controls and 344 elderly tumour-free women carried the 5382 insC variant.
82
Founder mutations in early-onset, familial and bilateral breast cancer patients from Russia.
Anna P. Sokolenko,Maxim E. Rozanov,Natalia V. Mitiushkina,Natalia Yu. Sherina,Aglaya G. Iyevleva,Elena V. Chekmariova,Konstantin G. Buslov,E. S. Shilov,Alexandr V. Togo,Elena M. Bit-Sava,Dmitry A. Voskresenskiy,Oleg L. Chagunava,Peter Devilee,Cees J. Cornelisse,Vladimir Semiglazov,Evgeny N. Imyanitov +15 more
TL;DR: The obtained data suggest that a significant fraction of hereditary BC cases in Russia can be diagnosed using only a limited number of simple PCR tests.
76
Coding polymorphisms in Casp5, Casp8 and DR4 genes may play a role in predisposition to lung cancer
Yulia M. Ulybina,Ekatherina Sh. Kuligina,Nathalia V. Mitiushkina,Maxim E. Rozanov,Alexandr O. Ivantsov,Daria N. Ponomariova,Alexandr V. Togo,Evgeny Levchenko,Vladimir A. Shutkin,Sergiu I. Brenister,Peter Devilee,Boris Zhivotovsky,Ari Hirvonen,Evgeny N. Imyanitov +13 more
TL;DR: The obtained data indicate that Casp5, Casp8 and DR4 gene polymorphisms may deserve consideration in large-scale case-control studies of LC risk modifiers.
40
CHEK2 1100delC mutation is frequent among Russian breast cancer patients.
Elena V. Chekmariova,Anna P. Sokolenko,Konstantin G. Buslov,Aglaya G. Iyevleva,Yulia M. Ulibina,Maxim E. Rozanov,Natalia V. Mitiushkina,Alexandr V. Togo,Matsko De,Dmitry A. Voskresenskiy,Oleg L. Chagunava,Peter Devilee,Cees J. Cornelisse,Vladimir Semiglazov,Evgeny N. Imyanitov +14 more
TL;DR: The obtained data point at potentially high clinical relevance of CHEK2 1100delC testing in females of Russian origin and warrant similar case-control studies in ethnically and geographically related regions, especially in Ukraine, Belarus and Baltic countries.
39
BRCA1 4153delA founder mutation in Russian ovarian cancer patients.
Nadezhda Yu Krylova,Oksana S Lobeiko,Anna P. Sokolenko,Aglaya G. Iyevleva,Maxim E. Rozanov,Natalia V. Mitiushkina,Madina M. Gergova,Tatiana V Porhanova,Adel F Urmancheyeva,Sergey Ya Maximov,Alexandr V. Togo,Evgeny N. Imyanitov +11 more
TL;DR: This study supports neither the Russian origin of BRCA1 4153delA mutation, nor its selectivity towards ovarian versus breast cancer predisposition.